NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 121 filers reported holding NURIX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,398,040 | -2.6% | 814,000 | +61.5% | 0.59% | -33.9% |
| Q3 2022 | $6,569,000 | -47.9% | 504,144 | -49.3% | 0.89% | -54.6% |
| Q2 2022 | $12,600,000 | -11.1% | 994,492 | -1.7% | 1.97% | +7.5% |
| Q1 2022 | $14,173,000 | -34.1% | 1,011,638 | +36.1% | 1.83% | -15.1% |
| Q4 2021 | $21,517,000 | +172.2% | 743,238 | +181.6% | 2.15% | +74.8% |
| Q3 2021 | $7,906,000 | – | 263,900 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |